Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Chemours (CC) over the last 10 years, with Q3 2025 value amounting to $16.0 million.

  • Chemours' Other Non Operating Income rose 16666.67% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year increase of 250000.0%. This contributed to the annual value of $13.0 million for FY2024, which is 8571.43% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Other Non Operating Income is $16.0 million, which was up 16666.67% from $2.0 million recorded in Q2 2025.
  • Chemours' Other Non Operating Income's 5-year high stood at $132.0 million during Q4 2021, with a 5-year trough of -$31.0 million in Q4 2022.
  • In the last 5 years, Chemours' Other Non Operating Income had a median value of $5.0 million in 2024 and averaged $17.4 million.
  • Data for Chemours' Other Non Operating Income shows a peak YoY increase of 92500.0% (in 2021) and a maximum YoY decrease of 30000.0% (in 2021) over the last 5 years.
  • Chemours' Other Non Operating Income (Quarter) stood at $132.0 million in 2021, then crashed by 123.48% to -$31.0 million in 2022, then surged by 70.97% to -$9.0 million in 2023, then surged by 133.33% to $3.0 million in 2024, then surged by 433.33% to $16.0 million in 2025.
  • Its Other Non Operating Income was $16.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $5.0 million in Q1 2025.